157 related articles for article (PubMed ID: 7889486)
1. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression?
Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
Cancer; 1995 Mar; 75(6 Suppl):1527-33. PubMed ID: 7889486
[TBL] [Abstract][Full Text] [Related]
2. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.
Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
Gastroenterology; 1995 Feb; 108(2):434-40. PubMed ID: 7835585
[TBL] [Abstract][Full Text] [Related]
3. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
4. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
[TBL] [Abstract][Full Text] [Related]
5. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
Smith AJ; Stern HS; Penner M; Hay K; Mitri A; Bapat BV; Gallinger S
Cancer Res; 1994 Nov; 54(21):5527-30. PubMed ID: 7923190
[TBL] [Abstract][Full Text] [Related]
6. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
7. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
8. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
Yuan P; Sun M; Zhang J; Zhu X; Shi D
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
[TBL] [Abstract][Full Text] [Related]
9. K-ras and p53 mutations in human colorectal aberrant crypt foci.
Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis.
Miyanishi K; Takayama T; Ohi M; Hayashi T; Nobuoka A; Nakajima T; Takimoto R; Kogawa K; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Oct; 121(4):865-74. PubMed ID: 11606500
[TBL] [Abstract][Full Text] [Related]
11. APC and K-ras gene mutation in aberrant crypt foci of human colon.
Yuan P; Sun MH; Zhang JS; Zhu XZ; Shi DR
World J Gastroenterol; 2001 Jun; 7(3):352-6. PubMed ID: 11819789
[TBL] [Abstract][Full Text] [Related]
12. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
[TBL] [Abstract][Full Text] [Related]
14. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
16. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
17. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
Dieterle CP; Conzelmann M; Linnemann U; Berger MR
Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
[TBL] [Abstract][Full Text] [Related]
18. Ras oncogene activation in benign and malignant colorectal tumours.
Spandidos DA; Glarakis IS; Kotsinas A; Ergazaki M; Kiaris H
Tumori; 1995; 81(3 Suppl):7-11. PubMed ID: 7571058
[TBL] [Abstract][Full Text] [Related]
19. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon.
Zaidi NH; Pretlow TP; O'Riordan MA; Dumenco LL; Allay E; Gerson SL
Carcinogenesis; 1995 Mar; 16(3):451-6. PubMed ID: 7697797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]